Evo Fund lowers stake in SymBio Pharmaceuticals to 31.67%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2025-12-05 14:48 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 31.67%, previous report: 32.27%.